Johns Hopkins Finds 20%-Prevalent Gut Bacterium Toxin Uses Claudin-4 to Trigger Colorectal Cancer
Updated
Updated · Newsweek · Jul 17
Johns Hopkins Finds 20%-Prevalent Gut Bacterium Toxin Uses Claudin-4 to Trigger Colorectal Cancer
2 articles · Updated · Newsweek · Jul 17
Summary
Nature-published research identified claudin-4 as the receptor that lets Bacteroides fragilis toxin latch onto colon cells, solving a mechanism scientists had chased for more than 15 years.
CRISPR screening showed that without claudin-4, the BFT toxin could not bind, blocking the chain in which it damages the gut lining, cleaves E-cadherin and drives inflammation tied to tumor growth.
Animal studies already point to a possible intervention: a claudin-4-mimicking decoy intercepted the toxin before it reached colon cells and prevented tissue damage.
Bacteroides fragilis can be found in up to 20% of healthy people, but researchers stressed that cancer risk is linked to toxin-producing ETBF strains, not harmless versions of the bacterium.
The finding strengthens evidence that some gut microbes can directly promote colorectal cancer, though Johns Hopkins researchers said human prevention or treatment studies are still needed.
Beyond blocking a single toxin, could a 'microbial cocktail' be engineered to protect our colons from cancer?
Can a molecular 'decoy' that neutralizes a gut toxin become the next frontier in colon cancer prevention?
Gut Toxin Claudin-4 Pathway: How Bacteroides fragilis Drives Colorectal Cancer and New Avenues for Prevention
Overview
A major breakthrough by Johns Hopkins researchers reveals how a common gut bacterium, Bacteroides fragilis, can directly trigger colorectal cancer. The study shows that the bacterium’s toxin (BFT) binds specifically to claudin-4, a protein on colon cells that usually helps seal the spaces between cells. This binding was not known before and is essential for the toxin’s next step: cleaving E-cadherin, another key protein that keeps the colon’s protective barrier intact. When this barrier is disrupted, it leads to chronic inflammation and increases the risk of cancer, highlighting a clear biological pathway from bacterial toxin to tumor formation.